Literature DB >> 31640892

Importance of operating room case scheduling on analyses of observed reductions in surgical site infections from the purchase and installation of capital equipment in operating rooms.

Franklin Dexter1, Johannes Ledolter2, Richard H Epstein3, Randy W Loftus4.   

Abstract

BACKGROUND: We review the impact of the consequences of operating room (OR) management decision making on power analyses for observational studies of surgical site infections (SSIs) among patients receiving care in ORs with interventions versus without interventions involving physical changes to ORs. Examples include ventilation systems, bactericidal lighting, and physical alterations to ORs.
METHODS: We performed a narrative review of operating room management and surgical site infection articles. We used 10-years of operating room data to estimate parameters for use in statistical power analyses.
RESULTS: Creating pivot tables or monthly control charts of SSI per case by OR and comparing among ORs with or without intervention is not recommended. This approach has low power to detect a difference in SSI rates among the ORs with or without the intervention. The reason is that appropriate OR case scheduling decision making causes risk factors for SSI to differ among ORs, even when stratifying by surgical specialty. Such risk factors include case duration, urgency, and American Society of Anesthesiologists' Physical Status. Instead, analyze SSI controlling for the OR, where the patient had surgery, and matching patients using these variables is preferable. With α = 0.05, 600 cases per OR, 5 intervention ORs, and 5 or 1 control patients for each intervention patient, reasonable power (≅94% or 78%, respectively) can be achieved to detect reductions (3.6% to 2.4%) in the incidence of SSI between ORs with or without the intervention.
CONCLUSIONS: By using this matched cohort design, the effect of the purchase and installation of capital equipment in ORs on SSI can be evaluated meaningfully.
Copyright © 2019 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Matched cohort study; Operating room management; Pivot table; Surgical site infection

Mesh:

Year:  2019        PMID: 31640892     DOI: 10.1016/j.ajic.2019.08.017

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  5 in total

1.  Sample times for surveillance of S. aureus transmission to monitor effectiveness and provide feedback on intraoperative infection control.

Authors:  Subhradeep Datta; Franklin Dexter; Johannes Ledolter; Russell T Wall; Randy W Loftus
Journal:  Perioper Care Oper Room Manag       Date:  2020-10-10

2.  Systematic study on the relationship between particulate matter and microbial counts in hospital operating rooms.

Authors:  Huiyi Tan; Keng Yinn Wong; Bemgba Bevan Nyakuma; Haslinda Mohamed Kamar; Wen Tong Chong; Syie Luing Wong; Hooi Siang Kang
Journal:  Environ Sci Pollut Res Int       Date:  2021-08-30       Impact factor: 5.190

3.  Futility of Cluster Designs at Individual Hospitals to Study Surgical Site Infections and Interventions Involving the Installation of Capital Equipment in Operating Rooms.

Authors:  Franklin Dexter; Johannes Ledolter; Richard H Epstein; Randy W Loftus
Journal:  J Med Syst       Date:  2020-03-07       Impact factor: 4.460

4.  Sample sizes for surveillance of S. aureus transmission to monitor effectiveness and provide feedback on intraoperative infection control including for COVID-19.

Authors:  Franklin Dexter; Johannes Ledolter; Russell T Wall; Subhradeep Datta; Randy W Loftus
Journal:  Perioper Care Oper Room Manag       Date:  2020-05-21

5.  Effects of Seamless Operating Room Nursing Combined with Multistyle Health Education on the Psychological State, Rehabilitation Quality, and Nursing Satisfaction in Patients with Internal Fixation of Femoral Fracture.

Authors:  Qingyan Liu; Juan Wang; Jie Han; Tongyang You; Lijuan Li
Journal:  J Healthc Eng       Date:  2022-04-05       Impact factor: 2.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.